Affymetrix Shares Drop 9 Percent, Caliper Rises | GenomeWeb
Shares in Affymetrix dropped 9 percent for the five-day trading period ended Tuesday. The firm’s stock has been fluctuating between nearly $27 per share and $24 per share for the past couple of months. On Tuesday, Affy’s stock closed at $24.44, its lowest point since closing at $24.21 on May 17.
 
Shares in Caliper Life Sciences rose 8.7 percent for the tracking period. The firm’s stock has risen steadily over the past three weeks.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.